statistiche ricercatore

Nome	#
miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS	76
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL	53
Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer	51
Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells.	50
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFRbeta Aptamer.	46
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b	46
miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells	43
An anti-PDGFRβ aptamer for selective delivery of small therapeutic peptide to cardiac cells.	41
Targeting Insulin Receptor with a Novel Internalizing Aptamer	41
Electrochemical detection of miRNA-222 by use of a magnetic bead-based bioassay.	36
miR-221/222 overexpression in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ.	34
c-FLIPL enhances anti-apoptotic Akt functions by modulation of Gsk3β activity.	32
miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED.	31
Selection of RNA aptamers targeting hypoxia in cancer	25
Totale	605

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	42	0	0	0	0	0	6	0	5	0	9	12	10
2020/2021	35	5	3	6	0	5	3	0	1	0	0	0	12
2021/2022	78	0	0	0	0	0	3	3	4	16	8	15	29
2022/2023	152	13	5	11	5	23	15	0	21	30	22	5	2
2023/2024	100	2	13	3	8	4	25	6	20	1	4	9	5
2024/2025	72	14	23	5	9	19	2	0	0	0	0	0	0
Totale													605